Form Type: 4

SEC EDGAR Link
Accession Number:0001437749-23-025479
Date:2023-09-07
Issuer: UROGEN PHARMA LTD. (URGN)
Original Submission Date:

Reporting Person:

SMITH JASON DREW
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2023-09-07 deemed execution date A 10,000 (a) ordinary shares 10,000 $0.00 10,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit ("rsu") represents a contingent right to receive one ordinary share of the issuer
f2 1/3 of the shares underlying the restricted stock units will vest on each of september 7, 2024, september 7, 2025 and september 7, 2026
WhaleWisdom Logo

Elevate your investments